vialroom

#retatrutide 2025-08-05

Tuesday11 messages4 participantstimes are UTC
Highlights from this day
  • never_for_sale — GI was about the same as tirzepatide for me, the difference was how fast it arrived 10:47
  • dublin_dose — follow up buying this is a completely different risk conversation from the licensed compounds and that gets said too rarely, i have it written down somewhere 11:14
  • dublin_dose — does the energy expenditure claim show up as anything you can feel 11:15
  • VialBot — Archive lookup: charge_state first appears in this channel on 2025-02-09. 11:17
  • charge_state — people insist on small steps because the side effects arrive faster than on the other two 11:20
NF

GI was about the same as tirzepatide for me, the difference was how fast it arrived

is there any long term safety data at all or is it phase 2 and hope

DD

sat at 10 for 3 months rather than climbing and it kept working, so i never went up

DD

follow up buying this is a completely different risk conversation from the licensed compounds and that gets said too rarely, i have it written down somewhere

does the energy expenditure claim show up as anything you can feel

Cited study
Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
New England Journal of Medicine · 2023
48 weeks, dose-ranging. A Phase 2 result is not a safety record.
VB

Archive lookup: charge_state first appears in this channel on 2025-02-09.

CS

people insist on small steps because the side effects arrive faster than on the other two

[edited]
CS

low and slow

lot-log.csv
659 rows · not retained in the public archive
⚠️1📉9